The global gamma knife market is on a significant growth trajectory, with market size projections reaching USD 702.5 million by 2033, up from USD 337.7 million in 2023. This robust growth reflects a compound annual growth rate (CAGR) of 7.6% from 2023 to 2033, driven by expanding applications, favorable reimbursement policies, and growth in emerging healthcare markets.
Key Market Drivers and Trends:
The rising adoption of gamma knife technology is attributed to several key trends:
- Favorable Reimbursement Policies: In various regions, improved reimbursement policies are making gamma knife treatment more affordable and accessible. This trend is enhancing patient access to gamma knife technology and spurring wider adoption across the globe.
- Expanding Applications: Originally employed primarily for brain tumor treatment, gamma knife technology is now being utilized for a broader range of neurological conditions, including arteriovenous malformations (AVMs), trigeminal neuralgia, and epilepsy. This expanded use case is anticipated to further drive market growth over the coming decade.
- Emerging Market Opportunities: Emerging economies, especially in Asia and Latin America, are experiencing substantial investments in healthcare infrastructure. This development opens up new growth opportunities for gamma knife technology providers to expand their footprint and improve treatment accessibility in these regions.
- Collaborative Efforts with Healthcare Institutions: Manufacturers are increasingly forming partnerships with healthcare providers to promote gamma knife technology, offer training for medical professionals, and increase overall accessibility. These collaborations are crucial in strengthening the presence of gamma knife solutions within healthcare systems worldwide.
Market Outlook:
The gamma knife market’s promising outlook is propelled by innovation and increasing demand for minimally invasive neurosurgical treatments. With the continued development of healthcare infrastructure and expanding applications, gamma knife technology is positioned as a critical tool in advanced neurological care.
Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!
Key Takeaways from the Market Study:
- Global gamma knife market was valued at USD 313.8 million by 2022-end.
- From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
- The market in India is expected to expand at a CAGR of 11.4% through 2033.
- By disease, the brain metastases segment to account for a share of 69.2% in 2033.
- From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
- By 2033, the market value of gamma knife is expected to reach USD 702.5 million.
Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.
Competitive Landscape:
Prominent players in the gamma knife market are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.
Recent Developments:
- In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
- In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.
Segmentation Analysis of the Gamma Knife Market
By Disease Indication:
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
By Anatomy:
- Head
- Neck
- Other Body Parts
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
The Middle East & Africa
